Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C
✍ Scribed by S. M. Martinez; G. Fernández-Varo; P. González; E. Sampson; M. Bruguera; M. Navasa; W. Jiménez; J. M. Sánchez-Tapias; X. Forns
- Book ID
- 108606122
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 291 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This study determined the utility of a panel of serum fibrosis markers along with routine laboratory tests in estimating the likelihood of histological cirrhosis in a cohort of prior nonresponders with chronic hepatitis C. The relationship between serum markers and quantitative hepatic collagen cont
Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive procedure with several limitations. A new, noninvasive medical device based on transient elastography has been designed t